KRKA: 2025 Unaudited consolidated financial statements of the Krka Group and unaudited financial statements of the Krka, d. d., Novo mesto

POLISH FINANCIAL SUPERVISION AUTHORITY

UNI - EN REPORT No

/

2026

Date of issue:

2026-03-12

Short name of the issuer

KRKA

Subject

2025 Unaudited consolidated financial statements of the Krka Group and unaudited financial statements of the Krka, d. d., Novo mesto

Official market - legal basis

Art. 17 ust. 1 MAR

Unofficial market - legal basis

Contents of the report:

Based on Article 26 of the Rules of the Ljubljana Stock Exchange, d. d., Ljubljana and Article 17 of Regulation (EU) no. 596/2014 company Krka, d. d., Novo mesto publishes 2025 Unaudited consolidated financial statements of the Krka Group and unaudited financial statements of the Krka d. d., Novo mesto with relavant notes.

The report will be published on the Company's website (www.krka.biz) from 12 March 2026 onwards, for a minimum period of 5 years.

Annexes

File

Description

2025 Unaudited consolidated financial statements of the Krka Group and unaudited financial statements of the Krka Company.pdf

2025 Unaudited consolidated financial statements of the Krka Group and unaudited financial statements of the Krka Company

Press Release.pdf

Press Release

KRKA, TOVARNA ZDRAVIL D.D.

(fullname of the issuer)

KRKA

Farmaceutyczny (far)

(short name of the issuer)

(sector according to clasification

of the WSE in Warsow)

8501

Nove Mesto

(post code)

(city)

Smarjeska

(street)

(number)

+386 7 331 21 11

+386 7 332 15 37

(phone number)

(fax)

(e-mail)

(web site)

nie dotyczy

(NIP)

(REGON)

SIGNATURE OF PERSONS REPRESENTING THE COMPANY

2026-03-12

Jože Colarič

President of the Management Board and CEO